| 生物活性 | Garcinoic acid is an orally active anti-inflammatory agent capable of crossing the blood-brain barrier that enhances efferocytosis and enzyme/receptor modulation, targets and inhibits human COX-2 (>10 μM), porcine α-amylase (IC50=28.91 μM), Saccharomyces cerevisiae α-glucosidase (IC50=41.08 μM), and human DNA polymerase β (IC50=11 μM), and agonizes human PXR, while enhancing macrophage efferocytosis through receptors such as MerTK and LRP-1, promoting the generation of pro-resolving lipid mediators, inhibiting NF-κB activation and pro-inflammatory cytokine secretion, interfering with Aβ aggregation, downregulating NLRP3 inflammasome activity, and binding to targets including CD44 and EGFR to suppress leukemia cell proliferation, with its pharmacological activities such as antioxidant, anti-inflammatory, and lipid metabolism-regulating effects being widely applied in research on various diseases including atherosclerosis, Alzheimer's disease, type 2 diabetes, inflammatory bowel disease, and viral pneumonia. | ||||||||||||||||||||||||
| IC50 & Target |
|
||||||||||||||||||||||||
| 体外研究 (In Vitro) |
Garcinoic acid (2.5 μM; 24 h, 14-24 h) 可抑制 LPS 诱导的小鼠 RAW264.7 巨噬细胞中 Cox2 和 iNos 蛋白表达,在 2.5 μM 浓度下可将 iNos 水平降至 LPS 对照组的 17%。 Western Blot Analysis
Cell Proliferation Assay
Cell Viability Assay
|
||||||||||||||||||||||||
| 体内研究 (In Vivo) |
Garcinoic acid (1 mg/kg;腹腔注射;每周 1 次;持续 8 周) 可显著降低高脂饮食喂养的 ApoE-/-小鼠的斑块内硝基酪氨酸水平,并调节部分全身及局部免疫细胞群,且不会改变动脉粥样硬化斑块大小或全身炎症介质水平。
|
| 分子量 | 426.59 |
| 分子式 | C27H38O4 |
| CAS No. | 91893-83-3 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。